Moderate to Severe Psoriasis Research Trial (24 Weeks)

Adults at least 18 years old and not more than 65 years of age with a clinical diagnosis of moderate to severe chronic plaque psoriasis with a

disease duration of at least 6 months, may qualify to participate. Individuals must have 10% or more body surface area (BSA) affected by plaque psoriasis, and have no other skin disease which may interfere with assessment of chronic plaque psoriasis.

Participants will receive investigational oral medication (active study drug) or placebo. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 24 weeks and involve about 8 visits to the study centre, plus a follow-up phone call.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more